Hemodialysis in chronic kidney disease--balancing fluid and salt on the inflammation tightrope.
Haemodialysis (HD) is a well-established, longstanding, and life-saving treatment for patients with chronic kidney disease (CKD) or acute kidney injury (AKI). However, side-effects of HD in CKD patients are numerous and remain problematic. Amongst others, CKD patients are susceptible to short-term effects caused by abnormalities in water and electrolyte balance and long-term effects related to sustained inflammation short-term side-effects of HD such as errors in sodium content of dialysate could readily be overcome by correct baseline labelling of dialysates and the ongoing rigorous implementation of safety procedures by staff nurses and physicians. The proper implementation of biofeedback systems, with tight safety alarm limits and conductivity based detection systems including the analysis of ionic mass balance could have prevented the shortfalls described. Long-term untoward effects of HD are mainly due to sustained inflammation and are correlated with higher morbidity and mortality. Unfortunately, the pathophysiologic mechanisms that underpin the inflammatory processes induced by HD remain poorly understood or incompletely unravelled. Within the wide array of inflammatory (inter)actions, cytokines are undoubtedly key players but interesting biomarkers (e.g. follistatin) and pathways (e.g. erythropoietin hyporesponsiveness) have come into play. Therapeutic interventions in differing fields such as vascular access, avoidance of intra-dialytic hypotension and pharmacologic interventions with statins, angiotensin II receptor antagonists or vitamine D supplementation may be of significance. However, confirmatory trials investigating of all these promising therapies are, as yet, lacking. The impact of the dialysis technique itself should not be underestimated.
Department of Intensive Care Medicine (KRIT Research Group), Iniversitair Ziekenhuis Brussel (UZ-Brussel), Vrije Universitieit Brussel, Brussels - Belgium. Patrick.Honore@uzbrussel.be
Patrick M
PM
Honoré
Rita
R
Jacobs
Olivier
O
Joannes-Boyau
Willem
W
Boer
Eisabeth
E
De Waele
Jouke
J
De Regt
Herbert D
HD
Spapen
D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D015312:Hemodialysis Solutions / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D006435:Renal Dialysis / Q000379:methods*; D012964:Sodium / Q000008:administration & dosage*; D015430:Weight Gain / Q000187:drug effects*
D015312:Hemodialysis Solutions; D012964:Sodium